Compare Abbott India with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ELDER PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ELDER PHARMA ABBOTT INDIA/
ELDER PHARMA
 
P/E (TTM) x 48.6 -0.2 - View Chart
P/BV x 15.7 0.1 15,577.5% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ABBOTT INDIA   ELDER PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
ELDER PHARMA
Jun-14
ABBOTT INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs8,834380 2,324.8%   
Low Rs5,458188 2,902.9%   
Sales per share (Unadj.) Rs1,731.1491.2 352.4%  
Earnings per share (Unadj.) Rs211.9-3.2 -6,660.8%  
Cash flow per share (Unadj.) Rs219.914.4 1,526.1%  
Dividends per share (Unadj.) Rs65.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs945.2376.5 251.0%  
Shares outstanding (eoy) m21.2520.54 103.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.10.6 713.9%   
Avg P/E ratio x33.7-89.3 -37.8%  
P/CF ratio (eoy) x32.519.7 164.9%  
Price / Book Value ratio x7.60.8 1,002.3%  
Dividend payout %30.70-   
Avg Mkt Cap Rs m151,8485,833 2,603.1%   
No. of employees `0003.5NA-   
Total wages/salary Rs m4,3562,179 199.9%   
Avg. sales/employee Rs Th10,555.5NM-  
Avg. wages/employee Rs Th1,249.9NM-  
Avg. net profit/employee Rs Th1,292.2NM-  
INCOME DATA
Net Sales Rs m36,78610,089 364.6%  
Other income Rs m1,133257 441.5%   
Total revenues Rs m37,91910,346 366.5%   
Gross profit Rs m6,047-792 -763.6%  
Depreciation Rs m169361 46.8%   
Interest Rs m232,756 0.8%   
Profit before tax Rs m6,989-3,653 -191.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m2,485125 1,985.8%   
Profit after tax Rs m4,503-65 -6,891.0%  
Gross profit margin %16.4-7.8 -209.4%  
Effective tax rate %35.6-3.4 -1,038.0%   
Net profit margin %12.2-0.6 -1,890.0%  
BALANCE SHEET DATA
Current assets Rs m27,6109,240 298.8%   
Current liabilities Rs m8,5699,998 85.7%   
Net working cap to sales %51.8-7.5 -689.2%  
Current ratio x3.20.9 348.6%  
Inventory Days Days6046 130.0%  
Debtors Days Days2760 45.7%  
Net fixed assets Rs m1,05710,124 10.4%   
Share capital Rs m213206 103.3%   
"Free" reserves Rs m19,8735,582 356.0%   
Net worth Rs m20,0867,734 259.7%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m29,40922,882 128.5%  
Interest coverage x311.6-0.3 -95,791.1%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.30.4 283.7%   
Return on assets %15.411.8 130.9%  
Return on equity %22.4-0.8 -2,653.2%  
Return on capital %34.922.3 156.5%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m369307 120.3%   
Fx outflow Rs m4,918125 3,925.3%   
Net fx Rs m-4,549181 -2,509.4%   
CASH FLOW
From Operations Rs m4,99111,754 42.5%  
From Investments Rs m-2,570-561 458.5%  
From Financial Activity Rs m-1,428-6,762 21.1%  
Net Cashflow Rs m9934,432 22.4%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 7.5 105.3%  
FIIs % 0.1 16.8 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 36.1 47.4%  
Shareholders   18,270 16,479 110.9%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   UNICHEM LAB  AUROBINDO PHARMA  STERLING BIOTECH  GLENMARK PHARMA  SUN PHARMA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

March Quarter Results, Aditya Birla Sun Life AMC IPO and Buzzing Stocks Today(Pre-Open)

On Tuesday, Indian share markets witnessed volatile trading activity and ended lower.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Apr 20, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS